Home › Breckenridge Announces Approval Of Rizatriptan Benzoate Tablets
 

Keywords :   


Breckenridge Announces Approval Of Rizatriptan Benzoate Tablets

2013-01-02 01:42:40| drugdiscoveryonline News Articles

Breckenridge Pharmaceutical, Inc.announced today the immediate launch of Rizatriptan Benzoate Tablets. The U.S. Food and Drug Administration granted finalapproval for the Abbreviated New Drug Application (ANDA) for this product, which is being manufactured and supplied by Natco Pharma Limited, and will be available in both 5mg and 10mg strengths

Tags: approval announces tablets breckenridge

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 23
More »